From Campus to CES®: KHU Startups and Students on a Global Mission
Four Startups, Student Supporters, and Research Programs from Kyung Hee to Highlight Innovative Startup Achievements and Facilitate Global Market Expansion...
News
Kinetic Seas CEO releases public shareholder letter
SCHAUMBURG, Ill., Dec. 23, 2024 /PRNewswire/ -- Kinetic Seas (OTC:KSEZ) Dear Fellow Shareholders, It is remarkable to reflect on the progress...
HISENSE TO UNVEIL “AI YOUR LIFE” VISION AT CES 2025
DUBAI, UAE, Dec. 23, 2024 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, is set to...
Hochul Signs Step Therapy Reform Measures Into Law
New law limits methods health insurers and PBMs can use to delay and discourage access to medically necessary treatments. ALBANY,...
Safe Haven Baby Boxes Celebrates Remarkable 2024 Milestones: 300th Baby Box Blessed and Expanded Outreach
WOODBURN, INDIANA / ACCESSWIRE / December 23, 2024 / Safe Haven Baby Boxes is proud to conclude 2024 with monumental...
Open Healthcare Inc. Expands U.S. Operations With CTON Laboratory Acquisition, New Facility in Gardena, and Appointment of New COO
LOS ANGELES, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Open Healthcare Inc., a global leader in healthcare services, announces...
China’s Digital Healthcare Transformation: Local Vendors Lead 2025 EHR Adoption, Highlights Black Book Research
China's healthcare digitalization is being driven by urban innovation, government-backed initiatives, and the dominance of local and regional EHR vendors....
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000
CHICAGO, IL / ACCESSWIRE / December 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment The Company is gearing...
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which helps childhood cancer survivors pursue...
Honeycomb Clinic Positions for Public Offering
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024 / Honeycomb Clinic, the innovative...
Ensysce Biosciences Regains Full Compliance with Nasdaq
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical...
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in...
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months...
NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape
SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), says that its broad-spectrum antiviral...
GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds
– Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA,...
XBiotech Pauses Rheumatology program
Findings from recently completed Rheumatoid Arthritis Study raise questionsAUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today...
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI...
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
WASHINGTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical...